We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-11.43%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$19.8B
AUM Growth
-$2.83B
Cap. Flow
+$212M
Cap. Flow %
1.07%
Top 10 Hldgs %
15.28%
Holding
2,395
New
108
Increased
1,282
Reduced
892
Closed
107

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$32.7M
2
CI icon
Cigna
CI
+$31.5M
3
LYB icon
LyondellBasell Industries
LYB
+$27.6M
4
VICI icon
VICI Properties
VICI
+$24.4M
5
CVS icon
CVS Health
CVS
+$21.2M

Sector Composition

Rank Sector Weight
1 Technology 17.58%
2 Financials 16.18%
3 Healthcare 14.54%
4 Consumer Discretionary 9.94%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOSP icon
1601
Innospec
IOSP
$2.12B
$570K ﹤0.01%
9,223
+86
+0.9% +$5.92K
PFSI icon
1602
PennyMac Financial
PFSI
$3.94B
$570K ﹤0.01%
26,819
-2,386
-8% -$48.8K
ACHC icon
1603
Acadia Healthcare
ACHC
$2.62B
$568K ﹤0.01%
22,064
+2
+0% +$69
CLH icon
1604
Clean Harbors
CLH
$16.7B
$567K ﹤0.01%
11,489
+462
+4% +$28.8K
WHG icon
1605
Westwood Holdings Group
WHG
$182M
$567K ﹤0.01%
16,700
+11,586
+227% +$476K
SUPN icon
1606
Supernus Pharmaceuticals
SUPN
$2.65B
$566K ﹤0.01%
17,039
-120
-0.7% -$5.16K
EBIX
1607
DELISTED
Ebix Inc
EBIX
$566K ﹤0.01%
13,304
+7,055
+113% +$376K
BF.A icon
1608
Brown-Forman Class A
BF.A
$13.4B
$565K ﹤0.01%
11,906
-5,020
-30% -$240K
BID
1609
DELISTED
Sotheby's
BID
$564K ﹤0.01%
14,184
+1,329
+10% +$54.2K
NFBK
1610
DELISTED
Northfield Bancorp
NFBK
$563K ﹤0.01%
41,575
+25,017
+151% +$347K
PSEC icon
1611
Prospect Capital
PSEC
$1.08B
$563K ﹤0.01%
89,148
+12,170
+16% +$82.2K
GWB
1612
DELISTED
Great Western Bancorp, Inc.
GWB
$563K ﹤0.01%
18,022
+1,561
+9% +$56.8K
BRC icon
1613
Brady Corp
BRC
$4.39B
$562K ﹤0.01%
12,937
+1,888
+17% +$78.7K
DLPH
1614
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$560K ﹤0.01%
39,075
+12,988
+50% +$253K
HNI icon
1615
HNI Corp
HNI
$3.14B
$559K ﹤0.01%
15,788
+2,829
+22% +$107K
GEO icon
1616
The GEO Group
GEO
$4.1B
$556K ﹤0.01%
28,211
-4,949
-15% -$112K
SCSC icon
1617
Scansource
SCSC
$1.15B
$556K ﹤0.01%
16,184
+1,519
+10% +$57.2K
ALG icon
1618
Alamo Group
ALG
$1.92B
$555K ﹤0.01%
7,178
+580
+9% +$48.3K
FN icon
1619
Fabrinet
FN
$15.7B
$555K ﹤0.01%
10,807
+1,947
+22% +$93.3K
PAAS icon
1620
Pan American Silver
PAAS
$18.6B
$555K ﹤0.01%
37,995
-137,590
-78% -$1.97M
ALGT icon
1621
Allegiant Air
ALGT
$2.66B
$552K ﹤0.01%
5,508
+434
+9% +$51.8K
ESI icon
1622
Element Solutions
ESI
$8.68B
$552K ﹤0.01%
53,483
+13,719
+35% +$151K
MTRX icon
1623
Matrix Service
MTRX
$320M
$549K ﹤0.01%
30,592
-15,274
-33% -$312K
SCS
1624
DELISTED
Steelcase
SCS
$549K ﹤0.01%
37,027
+5,193
+16% +$84.4K
NXTM
1625
DELISTED
NxStage Medical Inc.
NXTM
$549K ﹤0.01%
19,159
+3,031
+19% +$86.1K

Similar funds

Aperio Group's Q4 2018 Portfolio in Review

As of Q4 2018, Aperio Group held 2,395 positions worth $19.8B, down 12% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q4 2018 filing shows 108 new, 1,282 increased, 892 reduced and 107 closed positions. Its largest new stake was Linde: 206,771 shares worth $32.3M. The largest sale was Aetna Inc, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2018 buy was Linde: 206,771 shares worth $32.3M.
  • Aperio Group added most to Cigna in Q4 2018, an estimated $31.5M increase.
  • Aperio Group's biggest Q4 2018 reduction was Apple, cutting an estimated $28.3M.
  • Aperio Group fully exited Aetna Inc in Q4 2018, selling an estimated $67.4M.
  • Aperio Group's ten largest holdings make up 15% of its $19.8B portfolio in Q4 2018.
  • Aperio Group opened 108 new positions and closed 107 in Q4 2018.
  • Aperio Group's portfolio value fell 12% quarter-over-quarter to $19.8B.

Based on Aperio Group's 13F filing for Q4 2018, filed 14 Feb 2019.